Gaps in Patient-Facing Information on Artificial Intelligence in Cancer Care: A Cross-Sectional Analysis
- 1 April 2026
- journal article
- Published by American Society of Clinical Oncology (ASCO) in JCO Clinical Cancer Informatics
- Vol. 10 (2) , e2600114
Abstract
PURPOSE: Artificial intelligence (AI) is increasingly integrated into cancer care and accessible to patients, yet the quality and accessibility of patient-facing information on this topic are poorly characterized. We evaluated the quality, readability, and AI safety concept coverage of publicly available Webpages and YouTube videos that patients are likely to encounter when searching to learn about AI in cancer care. METHODS: We conducted a cross-sectional analysis of digital content identified using Google Trends–derived search terms on August 6, 2025. Two independent reviewers screened the first 170 Google and 150 YouTube results for patient-facing content relevant to AI in cancer care, with discrepancies resolved by a third reviewer. Information quality was assessed using DISCERN (scale 1-5; ≥4 = high quality). Webpage readability was evaluated using Flesch-Kincaid (FK), Gunning Fog (GF), and Simplified Measure of Gobbledygook (SMOG) indices. Coverage of AI safety concepts (hallucination risk, clinician oversight, bias/equity, transparency) was assessed. RESULTS: Of the 320 resources screened, 52 Webpages (31%) and 30 videos (20%) met inclusion criteria. Median DISCERN scores were 2.5 (IQR, 2.5-4.0) for Webpages and 2.25 (IQR, 1.5-3.0) for videos, indicating overall low-quality information. Only 17 Webpages (33%) and seven videos (23%) were of high quality. Median Webpage readability corresponded to college level across all indices (FK 12.5, GF 15.0, SMOG 14.3), exceeding the sixth- to eighth-grade reading level recommended by the American Medical Association and National Institutes of Health. Most Webpages addressed clinician oversight (79%) and transparency (79%), but few discussed hallucination risk (15%). CONCLUSION: Patient-facing online information about AI in cancer care is limited, low in quality, difficult to read, and frequently omits safety concepts, highlighting an urgent need for accessible, high-quality resources.Keywords
This publication has 24 references indexed in Scilit:
- FDA-authorized oncology artificial intelligence and machine learning devices and their clinical evidence: A cross-sectional analysisJournal of Cancer Policy, 2026
- Assessment of the quality, readability, and usefulness of ChatGPT generated medical information for ten common cancer typesUniversal Access in the Information Society, 2024
- Artificial intelligence in oncology: ensuring safe and effective integration of language models in clinical practiceThe Lancet Regional Health - Europe, 2024
- Readability and Information Quality in Cancer Information From a Free vs Paid ChatbotJAMA Network Open, 2024
- Quality and Accessibility of Liquid Biopsy InformationJAMA Network Open, 2024
- Assessing the potential of GPT-4 to perpetuate racial and gender biases in health care: a model evaluation studyThe Lancet Digital Health, 2023
- Use of Artificial Intelligence Chatbots for Cancer Treatment InformationJAMA Oncology, 2023
- The false hope of current approaches to explainable artificial intelligence in health careThe Lancet Digital Health, 2021
- Quality Assessment of Online Resources for the Most Common CancersJournal of Cancer Education, 2021
- Readability analysis of online resources related to lung cancerJournal of Surgical Research, 2016